R01AG077011

EALIGN: A Patient Portal-Based Intervention to Align Medications with What Matters Most - Project Summary

Older adults with Alzheimer's disease and related dementias (ADRD) often take multiple medications and use potentially inappropriate medications (PIM), placing them at increased risk of adverse drug events, drug interactions, treatment burden, and mortality. Deprescribing (reducing or stopping medications that are harmful or unlikely to be beneficial) can improve outcomes for people living with dementia (PLWD).

The overarching goal of this proposal is to refine and pilot an intervention in which ADRD care partners are identified in primary care and provided with educational materials through the patient portal to engage them in deprescribing for PLWD. We propose a multicomponent intervention, EALIGN, which includes:

1) Facilitated patient portal registration for both PLWD and care partners; and
2) Delivery of a patient portal intervention to align medication decisions with PLWD and care partners' goals, provide care partner training in nonpharmacologic treatment of behavioral and psychological symptoms of dementia, and reduce polypharmacy and PIM use.

We propose the following specific aims:

In Aim 1, we characterize triadic interactions regarding medication use from two complementary perspectives. In Aim 1A, we assess how communication dynamics and characteristics of PLWD and care partners affect uptake of deprescribing recommendations during consultation with a clinical pharmacist. We qualitatively analyze content of 120 audiorecorded visits conducted as part of an ongoing, pharmacist-led deprescribing intervention for PLWD and their care partners in primary care. In Aim 1B, we identify individual (PLWD) and contextual (health system, clinic, clinician) factors that affect use of the patient portal for medication management among PLWD by examining uptake and use of the patient portal from date and time-stamped electronic interactions of N=7,500 PLWD receiving primary care in two health systems.

In Aim 2, we iteratively refine the EALIGN protocol through a user-centered design process involving in-depth interviews with key stakeholders (N=15-20 patient-care partner dyads and 10-15 frontline staff, clinicians, clinical informaticists, and health system leaders) at both health care systems.

In Aim 3, we will pilot the resultant EALIGN protocol with a total of 100 patient-care partner dyads at both health care systems to establish feasibility, acceptability, and preliminary efficacy for a future multisite cluster randomized trial. We will conduct a two-group pilot randomized trial to examine feasibility of measuring two primary outcomes (total number of chronic daily medications and rates of PIM prescriptions among PLWD) and one caregiver-reported secondary outcome, the Family Caregiver Medication Administration Hassles Scale.

This work will establish the preliminary data, methods, and partnerships to undertake a multisite embedded pragmatic clinical trial of a triadic-based behavioral intervention to promote patient and care partner engagement, foster care that aligns with patients' values, and promote improved health and well-being outcomes for PLWD and their care partners.

The Johns Hopkins University

TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.

93.866 - Aging Research

National Institute on Aging (NIA) [HHS - NIH]

Baltimore, Maryland 212051832 United States

Single Zip Code

Triadic Interactions in Clinical Encounters Involving People with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional) (RFA-AG-22-020)

Amendment Since initial award the total obligations have increased 281% from $831,572 to $3,167,469.